US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NLS Pharmaceutics Ltd.

0.7620

0.0000

Volume:- -

Turnover:- -

Market Cap:3.97M

PE:- -

High:0.7620

Open:0.7620

Low:0.7620

Close:0.7620

52wk High:30.80

52wk Low:0.7620

Shares:5.21M

Float Shares:3.42M

Volume Ratio:3.99

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(LYR):-2.6288

ROE:-862.92%

ROA:-75.98%

PB:1.41

PE(LYR):-0.29

Loading ...

Overview Company News Filings

Kadimastem Ltd Subsidiary of NLS Pharmaceutics Ltd Reports Six Month Loss of 11204 Thousand USD on No Reported Sales or Revenues with Increased Net Loss and No EPS Data Provided

NLS Pharmaceutics H1 EPS $(1.05) Up From $(1.94) YoY

NLS Pharmaceutics Shareholders Approve Merger with Kadimastem, Paving Way for Launch of NewCelX on Nasdaq

BRIEF-NLS Pharmaceutics Shareholders Approve Merger with Kadimastem and Related Proposals at Extraordinary General Meeting

NLS Pharmaceutics files to sell 5M common shares for holders

NLS Pharmaceutics AG Appoints CBIZ as New Auditor Amid Internal Control Weaknesses

NLS Pharmaceutics Engages New Accounting Firm After Marcum’s Resignation

BRIEF-Kadimastem, NLS Pharmaceutics Announce Effectiveness Of SEC Registration Statement For Proposed Merger

NLS Pharmaceutics and Kadimastem Secure SEC Approval for Merger, Set to Form NewCelX Ltd

Press Release: Kadimastem and NLS Pharmaceutics Announce Effectiveness of SEC Registration Statement in Connection with Proposed Merger

NLS Pharmaceutics and Kadimastem Secure Hong Kong Patent for IsletRx Cell-Selection Technology in Diabetes Treatment

Swiss stocks - Factors to watch on September 1

BRIEF-NLS Pharmaceutics AG Agreed To Extend Merger Agreement Termination Date With Kadimastem From Aug 31 To Oct 31

NLS Pharmaceutics Ag: Agreed to Extend Merger Agreement Termination Date With Kadimastem From Aug 31 to Oct 31- SEC Filing

THOMSON REUTERS

NLS Pharmaceutics AG Announces Seventh Amendment to Merger Agreement with Kadimastem Ltd

NLS Pharmaceutics AG Announces New Shareholder Agreement with Alpha Capital Anstalt to Exchange Warrants for Common Shares

NLS Pharmaceutics AG Announces Sixth Amendment to Merger Agreement with Kadimastem Ltd

NLS Pharmaceutics AG and Kadimastem Secure Milestone-Based Funding from BIRD Foundation Following FDA Pre-IND Success for iTOL-102, a Potential Cure for Type 1 Diabetes

NLS Pharmaceutics AG Held Extraordinary Shareholders' Meeting

NLS Pharmaceutics AG Announces Fifth Amendment to Merger Agreement with Kadimastem Ltd

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NLSP/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NLSP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NLSP\",,,,,undefined,":{"symbol":"NLSP","market":"US","secType":"STK","nameCN":"NLS Pharmaceutics Ltd.","latestPrice":0.762,"timestamp":1773345600000,"preClose":0.762,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":3417970,"shares":5206600,"eps":0,"marketStatus":"Pre-Mkt","change":0,"latestTime":"03-13 07:28:03 EDT","open":0.762,"high":0.762,"low":0.762,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1773408600000},"marketStatusCode":1,"symbolChange":{"newSymbol":"NCEL","executeDate":"2025-10-31"},"adr":0,"listingDate":1611896400000,"exchange":"NASDAQ","adjPreClose":0.762,"volumeRatio":3.985138275279038},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NLSP\",,,,,undefined,":{"symbol":"NLSP","floatShares":3417970,"roa":"-75.98%","roe":"-862.92%","lyrEps":-2.628804,"volumeRatio":3.985138275279038,"shares":5206600,"dividePrice":0,"high":0.762,"amplitude":0,"preClose":0.762,"low":0.762,"week52Low":0.762,"pbRate":"1.41","week52High":30.799,"institutionHeld":0,"latestPrice":0.762,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0.762},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NLSP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-10-31","symbol":"NLSP","defaultRemindTime":1761917400000,"type":"split","dateTimestamp":1761883200000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2025-10-31","symbol":"NLSP","oldSymbol":"NLSP","defaultRemindTime":1761917400000,"newSymbol":"NCEL","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1761883200000},{"market":"US","date":"2025-05-16","symbol":"NLSP","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747368000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-09-27","symbol":"NLSP","defaultRemindTime":1727443800000,"type":"split","dateTimestamp":1727409600000,"forFactor":40,"toFactor":1,"ratio":40}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NLSP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NLSP\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NLSP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NLSP","date":"2025-10-30","current":-1.418754,"percent":0.559657,"low":-21.132656,"twenty":-3.860074,"median":-1.657602,"eighty":-0.634248,"high":-0.319775,"avg":-3.265483,"sd":3.926926,"marketCap":3072521},"quantilePoints":[{"date":"2021-03-19","current":-14.991542,"twenty":-12.520647,"median":-11.018964,"eighty":-10.070324,"marketCap":48933998},{"date":"2021-03-26","current":-13.618823,"twenty":-13.683847,"median":-11.234625,"eighty":-10.184942,"marketCap":44453295},{"date":"2021-04-01","current":-14.88317,"twenty":-14.355756,"median":-11.674238,"eighty":-10.208698,"marketCap":48580259},{"date":"2021-04-09","current":-13.980065,"twenty":-14.19681,"median":-11.95711,"eighty":-10.288172,"marketCap":45632427},{"date":"2021-04-16","current":-11.559744,"twenty":-14.153461,"median":-11.812613,"eighty":-10.569724,"marketCap":37732240},{"date":"2021-04-23","current":-12.896339,"twenty":-14.081212,"median":-11.740365,"eighty":-10.641972,"marketCap":42095030},{"date":"2021-04-30","current":-13.221457,"twenty":-14.052313,"median":-11.920986,"eighty":-10.772091,"marketCap":43156249},{"date":"2021-05-07","current":-12.282228,"twenty":-14.008964,"median":-11.95711,"eighty":-10.801135,"marketCap":40090505},{"date":"2021-05-14","current":-14.171062,"twenty":-14.008964,"median":-11.920986,"eighty":-10.816166,"marketCap":40549572},{"date":"2021-05-21","current":-14.550644,"twenty":-14.181361,"median":-12.137731,"eighty":-10.83283,"marketCap":41635721},{"date":"2021-05-28","current":-14.550644,"twenty":-14.424117,"median":-12.318352,"eighty":-10.83726,"marketCap":41635721},{"date":"2021-06-04","current":-14.044534,"twenty":-14.339765,"median":-12.607345,"eighty":-10.905005,"marketCap":40187522},{"date":"2021-06-11","current":-14.381941,"twenty":-14.483163,"median":-12.896339,"eighty":-11.011559,"marketCap":41152988},{"date":"2021-06-18","current":-12.905788,"twenty":-14.365071,"median":-12.937188,"eighty":-11.03298,"marketCap":36929074},{"date":"2021-06-25","current":-13.707128,"twenty":-14.339765,"median":-13.032316,"eighty":-11.054005,"marketCap":39222056},{"date":"2021-07-02","current":-13.222106,"twenty":-14.339765,"median":-13.201019,"eighty":-11.111803,"marketCap":37834198},{"date":"2021-07-09","current":-12.99014,"twenty":-14.314459,"median":-13.090762,"eighty":-11.198501,"marketCap":37170441},{"date":"2021-07-16","current":-12.947964,"twenty":-14.209952,"median":-13.032316,"eighty":-11.212951,"marketCap":37049757},{"date":"2021-07-23","current":-12.357503,"twenty":-14.19681,"median":-12.99014,"eighty":-11.27075,"marketCap":35360192},{"date":"2021-07-30","current":-10.965703,"twenty":-14.19166,"median":-12.968587,"eighty":-11.212951,"marketCap":31377645},{"date":"2021-08-06","current":-10.783503,"twenty":-14.171062,"median":-12.905788,"eighty":-11.054005,"marketCap":30856293},{"date":"2021-08-13","current":-9.953484,"twenty":-14.162627,"median":-12.896339,"eighty":-11.025182,"marketCap":28481247},{"date":"2021-08-20","current":-9.700429,"twenty":-14.128886,"median":-12.787966,"eighty":-10.856045,"marketCap":27757147},{"date":"2021-08-27","current":-10.206538,"twenty":-14.128021,"median":-12.694909,"eighty":-10.806145,"marketCap":29205346},{"date":"2021-09-03","current":-11.176581,"twenty":-14.110111,"median":-12.452351,"eighty":-10.797826,"marketCap":31981061},{"date":"2021-09-10","current":-11.640515,"twenty":-14.052313,"median":-12.355989,"eighty":-10.801135,"marketCap":33308577},{"date":"2021-09-17","current":-11.09223,"twenty":-14.052313,"median":-12.282228,"eighty":-10.801135,"marketCap":31739694},{"date":"2021-09-24","current":-10.923526,"twenty":-14.044534,"median":-12.083545,"eighty":-10.796999,"marketCap":31256961},{"date":"2021-10-01","current":-4.821474,"twenty":-14.002359,"median":-11.884861,"eighty":-10.728526,"marketCap":30050129},{"date":"2021-10-08","current":-4.763384,"twenty":-13.980065,"median":-11.850246,"eighty":-10.512142,"marketCap":29688079},{"date":"2021-10-15","current":-4.666567,"twenty":-13.943941,"median":-11.740365,"eighty":-10.331521,"marketCap":29084663},{"date":"2021-10-22","current":-4.947861,"twenty":-13.799444,"median":-11.726617,"eighty":-10.176615,"marketCap":30837848},{"date":"2021-10-29","current":-4.646687,"twenty":-13.707128,"median":-11.640515,"eighty":-9.99566,"marketCap":28960761},{"date":"2021-11-05","current":-4.625175,"twenty":-13.654947,"median":-11.609223,"eighty":-9.700429,"marketCap":28826684},{"date":"2021-11-12","current":-4.560637,"twenty":-13.622776,"median":-11.559744,"eighty":-9.645161,"marketCap":28424451},{"date":"2021-11-19","current":-4.216438,"twenty":-13.618823,"median":-11.38746,"eighty":-8.489186,"marketCap":26279209},{"date":"2021-11-26","current":-4.330454,"twenty":-13.561024,"median":-11.308017,"eighty":-5.001323,"marketCap":26989820},{"date":"2021-12-03","current":-3.170934,"twenty":-13.517675,"median":-11.218757,"eighty":-4.926036,"marketCap":19763038},{"date":"2021-12-10","current":-3.099943,"twenty":-13.452652,"median":-11.187541,"eighty":-4.840837,"marketCap":19320582},{"date":"2021-12-17","current":-3.099943,"twenty":-13.383418,"median":-11.134406,"eighty":-4.818787,"marketCap":19320582},{"date":"2021-12-23","current":-3.170934,"twenty":-13.369722,"median":-11.09223,"eighty":-4.80211,"marketCap":19763038},{"date":"2021-12-31","current":-2.626669,"twenty":-13.293805,"median":-11.054005,"eighty":-4.763384,"marketCap":16370874},{"date":"2022-01-07","current":-2.886969,"twenty":-13.243194,"median":-11.018964,"eighty":-4.681107,"marketCap":17993213},{"date":"2022-01-14","current":-2.579342,"twenty":-13.243194,"median":-10.944615,"eighty":-4.666567,"marketCap":16075904},{"date":"2022-01-21","current":-2.224386,"twenty":-13.234759,"median":-10.923526,"eighty":-4.63378,"marketCap":13863623},{"date":"2022-01-28","current":-1.987749,"twenty":-13.221846,"median":-10.83726,"eighty":-4.522646,"marketCap":12388770},{"date":"2022-02-04","current":-2.149846,"twenty":-13.221457,"median":-10.813661,"eighty":-4.326582,"marketCap":13399044},{"date":"2022-02-11","current":-2.43736,"twenty":-13.213282,"median":-10.796999,"eighty":-4.160076,"marketCap":15190992},{"date":"2022-02-18","current":-2.839642,"twenty":-13.201019,"median":-10.769163,"eighty":-3.710466,"marketCap":17698243},{"date":"2022-02-25","current":-2.671867,"twenty":-13.201019,"median":-10.741675,"eighty":-3.265588,"marketCap":16652571},{"date":"2022-03-04","current":-3.383907,"twenty":-13.190657,"median":-10.712648,"eighty":-3.180399,"marketCap":21090406},{"date":"2022-03-11","current":-3.241925,"twenty":-13.134265,"median":-10.485868,"eighty":-3.180399,"marketCap":20205494},{"date":"2022-03-18","current":-2.934297,"twenty":-13.066056,"median":-10.375241,"eighty":-3.133072,"marketCap":18288184},{"date":"2022-03-25","current":-1.753121,"twenty":-13.032316,"median":-10.214843,"eighty":-3.099943,"marketCap":20942921},{"date":"2022-04-01","current":-1.679045,"twenty":-13.023881,"median":-10.176615,"eighty":-3.076279,"marketCap":20058008},{"date":"2022-04-08","current":-1.456819,"twenty":-12.99014,"median":-10.058923,"eighty":-3.005335,"marketCap":17403272},{"date":"2022-04-14","current":-1.546489,"twenty":-12.99014,"median":-9.974572,"eighty":-2.957961,"marketCap":18474476},{"date":"2022-04-22","current":-1.516749,"twenty":-12.99014,"median":-9.869132,"eighty":-2.930984,"marketCap":18119198},{"date":"2022-04-29","current":-1.577433,"twenty":-12.968587,"median":-9.700429,"eighty":-2.839642,"marketCap":18844132},{"date":"2022-05-06","current":-1.177691,"twenty":-12.947964,"median":-9.645161,"eighty":-2.815978,"marketCap":14068790},{"date":"2022-05-13","current":-1.067449,"twenty":-12.905788,"median":-9.085235,"eighty":-2.673996,"marketCap":12751833},{"date":"2022-05-20","current":-1.044444,"twenty":-12.905788,"median":-8.236317,"eighty":-2.662165,"marketCap":12477009},{"date":"2022-05-27","current":-1.196648,"twenty":-12.905788,"median":-4.984708,"eighty":-2.532014,"marketCap":14295245},{"date":"2022-06-03","current":-1.25186,"twenty":-12.898229,"median":-4.952439,"eighty":-2.498885,"marketCap":14954822},{"date":"2022-06-10","current":-0.908566,"twenty":-12.870157,"median":-4.879564,"eighty":-2.432627,"marketCap":10853795},{"date":"2022-06-17","current":-0.854657,"twenty":-12.831994,"median":-4.851324,"eighty":-2.262248,"marketCap":10209803},{"date":"2022-06-24","current":-0.923708,"twenty":-12.780741,"median":-4.840568,"eighty":-2.178668,"marketCap":11034691},{"date":"2022-07-01","current":-0.803323,"twenty":-12.717682,"median":-4.818787,"eighty":-2.044542,"marketCap":9596564},{"date":"2022-07-08","current":-0.953994,"twenty":-12.694909,"median":-4.803728,"eighty":-1.843079,"marketCap":11396485},{"date":"2022-07-15","current":-0.966865,"twenty":-12.678039,"median":-4.792428,"eighty":-1.683897,"marketCap":11550247},{"date":"2022-07-22","current":-0.652653,"twenty":-12.57678,"median":-4.763384,"eighty":-1.645772,"marketCap":7796643},{"date":"2022-07-29","current":-0.559979,"twenty":-12.454451,"median":-4.743493,"eighty":-1.584496,"marketCap":6689555},{"date":"2022-08-05","current":-0.609042,"twenty":-12.408114,"median":-4.6682,"eighty":-1.550695,"marketCap":7275660},{"date":"2022-08-12","current":-0.651593,"twenty":-12.356292,"median":-4.667383,"eighty":-1.509983,"marketCap":7783980},{"date":"2022-08-19","current":-0.752595,"twenty":-12.338816,"median":-4.647204,"eighty":-1.456819,"marketCap":8990560},{"date":"2022-08-26","current":-0.769858,"twenty":-12.302087,"median":-4.597462,"eighty":-1.38638,"marketCap":9196782},{"date":"2022-09-02","current":-0.802566,"twenty":-12.253328,"median":-4.539125,"eighty":-1.270007,"marketCap":9587519},{"date":"2022-09-09","current":-1.342708,"twenty":-12.195529,"median":-4.4961,"eighty":-1.253627,"marketCap":16040100},{"date":"2022-09-16","current":-1.465007,"twenty":-12.116056,"median":-4.327227,"eighty":-1.262046,"marketCap":17501084},{"date":"2022-09-23","current":-1.458493,"twenty":-12.014908,"median":-4.216438,"eighty":-1.270754,"marketCap":17423276},{"date":"2022-09-30","current":-1.009563,"twenty":-11.94266,"median":-4.152976,"eighty":-1.251566,"marketCap":12060323},{"date":"2022-10-07","current":-1.074696,"twenty":-11.878168,"median":-3.893752,"eighty":-1.196058,"marketCap":12838408},{"date":"2022-10-14","current":-0.632845,"twenty":-11.851394,"median":-3.573217,"eighty":-1.179921,"marketCap":10115109},{"date":"2022-10-21","current":-0.583191,"twenty":-11.850935,"median":-3.454898,"eighty":-1.156915,"marketCap":9321462},{"date":"2022-10-28","current":-0.905616,"twenty":-11.834576,"median":-3.348412,"eighty":-1.143349,"marketCap":14474959},{"date":"2022-11-04","current":-0.936321,"twenty":-11.769264,"median":-3.265588,"eighty":-1.1279,"marketCap":14965729},{"date":"2022-11-11","current":-0.832132,"twenty":-11.740365,"median":-3.24015,"eighty":-1.069487,"marketCap":13300419},{"date":"2022-11-18","current":-1.016015,"twenty":-11.737966,"median":-3.170934,"eighty":-1.064504,"marketCap":16239525},{"date":"2022-11-25","current":-1.414486,"twenty":-11.728369,"median":-3.123606,"eighty":-1.05569,"marketCap":22608507},{"date":"2022-12-02","current":-1.457439,"twenty":-11.724866,"median":-3.099943,"eighty":-1.063768,"marketCap":23295034},{"date":"2022-12-09","current":-1.494326,"twenty":-11.668116,"median":-3.076279,"eighty":-1.067449,"marketCap":23884634},{"date":"2022-12-16","current":-2.075105,"twenty":-11.640515,"median":-3.064447,"eighty":-1.067449,"marketCap":33167528},{"date":"2022-12-23","current":-2.658793,"twenty":-11.631992,"median":-3.005525,"eighty":-1.067633,"marketCap":42496933},{"date":"2022-12-30","current":-2.679565,"twenty":-11.622484,"median":-3.005288,"eighty":-1.068075,"marketCap":42828940},{"date":"2023-01-06","current":-3.510437,"twenty":-11.607046,"median":-2.97037,"eighty":-1.072092,"marketCap":56109232},{"date":"2023-01-13","current":-3.489695,"twenty":-11.575182,"median":-3.005407,"eighty":-1.089351,"marketCap":55777695},{"date":"2023-01-20","current":-2.901316,"twenty":-11.559744,"median":-2.987829,"eighty":-1.101338,"marketCap":46373316},{"date":"2023-01-27","current":-2.99691,"twenty":-11.558312,"median":-3.005288,"eighty":-1.113336,"marketCap":47901242},{"date":"2023-02-03","current":-2.883887,"twenty":-11.488682,"median":-3.001099,"eighty":-1.129458,"marketCap":46094735},{"date":"2023-02-10","current":-2.902123,"twenty":-11.38746,"median":-2.990124,"eighty":-1.136905,"marketCap":46386217},{"date":"2023-02-17","current":-2.968707,"twenty":-11.37059,"median":-2.96925,"eighty":-1.141288,"marketCap":47450463},{"date":"2023-02-24","current":-2.968707,"twenty":-11.330377,"median":-2.968707,"eighty":-1.143349,"marketCap":47450463},{"date":"2023-03-03","current":-2.968707,"twenty":-11.27075,"median":-2.968707,"eighty":-1.150711,"marketCap":47450463},{"date":"2023-03-10","current":-3.286783,"twenty":-11.260351,"median":-2.970081,"eighty":-1.15314,"marketCap":52534441},{"date":"2023-03-17","current":-3.180758,"twenty":-11.214706,"median":-2.99691,"eighty":-1.155887,"marketCap":50839782},{"date":"2023-03-24","current":-2.677138,"twenty":-11.198501,"median":-2.980247,"eighty":-1.156915,"marketCap":42790149},{"date":"2023-03-31","current":-3.223168,"twenty":-11.194117,"median":-2.97037,"eighty":-1.162089,"marketCap":51517645},{"date":"2023-04-06","current":-3.286783,"twenty":-11.176581,"median":-2.99691,"eighty":-1.172559,"marketCap":52534441},{"date":"2023-04-14","current":-3.307988,"twenty":-11.134406,"median":-3.005407,"eighty":-1.177691,"marketCap":52873373},{"date":"2023-04-21","current":-3.180758,"twenty":-11.134406,"median":-3.011117,"eighty":-1.177691,"marketCap":50839782},{"date":"2023-04-28","current":-3.06413,"twenty":-11.100665,"median":-3.032322,"eighty":-1.186612,"marketCap":48975656},{"date":"2023-05-05","current":-2.694314,"twenty":-11.09223,"median":-3.011117,"eighty":-1.191708,"marketCap":43064684},{"date":"2023-05-12","current":-2.587016,"twenty":-11.09223,"median":-3.005288,"eighty":-1.192564,"marketCap":41349689},{"date":"2023-05-19","current":-2.260138,"twenty":-11.069295,"median":-2.99691,"eighty":-1.194586,"marketCap":37282506},{"date":"2023-05-26","current":-2.167677,"twenty":-11.054005,"median":-2.970081,"eighty":-1.196353,"marketCap":35757313},{"date":"2023-06-02","current":-2.018588,"twenty":-11.052425,"median":-2.968707,"eighty":-1.20055,"marketCap":33297987},{"date":"2023-06-09","current":-1.822784,"twenty":-11.037618,"median":-2.968707,"eighty":-1.210581,"marketCap":30068069},{"date":"2023-06-16","current":-1.906925,"twenty":-11.016496,"median":-2.968707,"eighty":-1.221877,"marketCap":31456026},{"date":"2023-06-23","current":-2.024879,"twenty":-11.009091,"median":-2.963334,"eighty":-1.23696,"marketCap":33401759},{"date":"2023-06-30","current":-1.80863,"twenty":-10.982071,"median":-2.956973,"eighty":-1.24769,"marketCap":29834581},{"date":"2023-07-07","current":-2.339424,"twenty":-10.948832,"median":-2.947502,"eighty":-1.251639,"marketCap":38590382},{"date":"2023-07-14","current":-1.80863,"twenty":-10.923526,"median":-2.947502,"eighty":-1.255394,"marketCap":29834581},{"date":"2023-07-21","current":-1.727438,"twenty":-10.923526,"median":-2.947171,"eighty":-1.263397,"marketCap":28495268},{"date":"2023-07-28","current":-1.866624,"twenty":-10.889786,"median":-2.934297,"eighty":-1.271065,"marketCap":30791233},{"date":"2023-08-04","current":-1.729994,"twenty":-10.838409,"median":-2.926297,"eighty":-1.279483,"marketCap":28537425},{"date":"2023-08-11","current":-1.688513,"twenty":-10.83726,"median":-2.910633,"eighty":-1.284028,"marketCap":27853176},{"date":"2023-08-18","current":-1.602997,"twenty":-10.83283,"median":-2.908055,"eighty":-1.288992,"marketCap":26442519},{"date":"2023-08-25","current":-1.631699,"twenty":-10.816166,"median":-2.905092,"eighty":-1.314876,"marketCap":26915981},{"date":"2023-09-01","current":-2.00522,"twenty":-10.801135,"median":-2.901316,"eighty":-1.345188,"marketCap":33077470},{"date":"2023-09-08","current":-1.812562,"twenty":-10.801135,"median":-2.883887,"eighty":-1.355109,"marketCap":29899439},{"date":"2023-09-15","current":-1.709352,"twenty":-10.796999,"median":-2.852079,"eighty":-1.376458,"marketCap":28196922},{"date":"2023-09-22","current":-1.572722,"twenty":-10.796999,"median":-2.841477,"eighty":-1.392383,"marketCap":25943114},{"date":"2023-09-29","current":-1.367285,"twenty":-10.783503,"median":-2.829957,"eighty":-1.392383,"marketCap":22554295},{"date":"2023-10-06","current":-1.45752,"twenty":-10.754823,"median":-2.815978,"eighty":-1.392383,"marketCap":24042781},{"date":"2023-10-13","current":-1.494086,"twenty":-10.754823,"median":-2.791948,"eighty":-1.395791,"marketCap":24645958},{"date":"2023-10-20","current":-1.488974,"twenty":-10.728526,"median":-2.756657,"eighty":-1.401262,"marketCap":24561643},{"date":"2023-10-27","current":-1.060014,"twenty":-10.722175,"median":-2.741237,"eighty":-1.393746,"marketCap":17485659},{"date":"2023-11-03","current":-1.297889,"twenty":-10.712648,"median":-2.717785,"eighty":-1.370824,"marketCap":21409555},{"date":"2023-11-10","current":-1.376132,"twenty":-10.678907,"median":-2.694314,"eighty":-1.355654,"marketCap":22700225},{"date":"2023-11-17","current":-0.629089,"twenty":-10.581834,"median":-2.679565,"eighty":-1.301585,"marketCap":10377245},{"date":"2023-11-24","current":-0.786754,"twenty":-10.501632,"median":-2.675567,"eighty":-1.296557,"marketCap":12978042},{"date":"2023-12-01","current":-0.825482,"twenty":-10.451158,"median":-2.673996,"eighty":-1.269257,"marketCap":13616892},{"date":"2023-12-08","current":-0.914538,"twenty":-10.408982,"median":-2.660479,"eighty":-1.258099,"marketCap":15085921},{"date":"2023-12-15","current":-0.886219,"twenty":-10.366497,"median":-2.638021,"eighty":-1.221877,"marketCap":13707693},{"date":"2023-12-22","current":-0.933602,"twenty":-10.309846,"median":-2.611573,"eighty":-1.196058,"marketCap":14440586},{"date":"2023-12-29","current":-1.060654,"twenty":-10.244823,"median":-2.596477,"eighty":-1.191708,"marketCap":16405776},{"date":"2024-01-05","current":-1.19106,"twenty":-10.216504,"median":-2.583179,"eighty":-1.189729,"marketCap":18422854},{"date":"2024-01-12","current":-1.06925,"twenty":-10.198732,"median":-2.532014,"eighty":-1.174078,"marketCap":16538735},{"date":"2024-01-19","current":-1.006353,"twenty":-10.184942,"median":-2.508351,"eighty":-1.156915,"marketCap":15565868},{"date":"2024-01-26","current":-0.979307,"twenty":-10.174165,"median":-2.461023,"eighty":-1.143349,"marketCap":15147535},{"date":"2024-02-02","current":-1.048284,"twenty":-10.147493,"median":-2.43736,"eighty":-1.109,"marketCap":16214446},{"date":"2024-02-09","current":-1.048284,"twenty":-10.071576,"median":-2.3937,"eighty":-1.083826,"marketCap":16214446},{"date":"2024-02-16","current":-0.943435,"twenty":-10.0294,"median":-2.359083,"eighty":-1.067743,"marketCap":14592677},{"date":"2024-02-23","current":-0.859593,"twenty":-9.99566,"median":-2.339424,"eighty":-1.063768,"marketCap":13295846},{"date":"2024-03-01","current":-0.810952,"twenty":-9.953484,"median":-2.276199,"eighty":-1.048284,"marketCap":12543495},{"date":"2024-03-08","current":-0.744282,"twenty":-9.911308,"median":-2.260138,"eighty":-1.047065,"marketCap":11512257},{"date":"2024-03-15","current":-0.786397,"twenty":-9.869132,"median":-2.216578,"eighty":-1.027318,"marketCap":12163689},{"date":"2024-03-22","current":-0.398952,"twenty":-9.700429,"median":-2.198497,"eighty":-1.016015,"marketCap":6170829},{"date":"2024-03-28","current":-0.462398,"twenty":-9.700429,"median":-2.167677,"eighty":-1.006353,"marketCap":7152191},{"date":"2024-04-05","current":-0.43187,"twenty":-9.700429,"median":-2.158837,"eighty":-1.005766,"marketCap":6679999},{"date":"2024-04-12","current":-0.43005,"twenty":-9.666688,"median":-2.136857,"eighty":-1.000713,"marketCap":6651841},{"date":"2024-04-19","current":-0.404444,"twenty":-9.647779,"median":-2.113345,"eighty":-0.985387,"marketCap":6255787},{"date":"2024-04-26","current":-0.40353,"twenty":-9.492927,"median":-2.084053,"eighty":-0.972901,"marketCap":6241644},{"date":"2024-05-03","current":-0.414502,"twenty":-9.26031,"median":-2.078755,"eighty":-0.965677,"marketCap":6411357},{"date":"2024-05-10","current":-0.431265,"twenty":-9.009375,"median":-2.024879,"eighty":-0.964304,"marketCap":6670639},{"date":"2024-05-17","current":-0.455343,"twenty":-8.583109,"median":-2.00522,"eighty":-0.961435,"marketCap":7043064},{"date":"2024-05-24","current":-0.671385,"twenty":-8.286891,"median":-1.978757,"eighty":-0.951327,"marketCap":8172123},{"date":"2024-05-31","current":-0.643693,"twenty":-6.991906,"median":-1.965902,"eighty":-0.939852,"marketCap":7835055},{"date":"2024-06-07","current":-0.510462,"twenty":-5.472359,"median":-1.926585,"eighty":-0.928251,"marketCap":6213359},{"date":"2024-06-14","current":-0.383218,"twenty":-4.990246,"median":-1.921571,"eighty":-0.92249,"marketCap":4664538},{"date":"2024-06-21","current":-0.61638,"twenty":-4.957017,"median":-1.907023,"eighty":-0.914646,"marketCap":7502601},{"date":"2024-06-28","current":-0.7915,"twenty":-4.957017,"median":-1.906925,"eighty":-0.913391,"marketCap":9634159},{"date":"2024-07-05","current":-0.665519,"twenty":-4.953355,"median":-1.905942,"eighty":-0.908626,"marketCap":8100722},{"date":"2024-07-12","current":-0.676073,"twenty":-4.943778,"median":-1.86918,"eighty":-0.901027,"marketCap":8229177},{"date":"2024-07-15","current":-0.70916,"twenty":-4.941737,"median":-1.867902,"eighty":-0.899992,"marketCap":8631912},{"date":"2024-08-02","current":-0.741264,"twenty":-4.939695,"median":-1.866624,"eighty":-0.897385,"marketCap":9022692},{"date":"2024-08-09","current":-0.689187,"twenty":-4.891182,"median":-1.823374,"eighty":-0.88859,"marketCap":8388803},{"date":"2024-08-16","current":-0.610705,"twenty":-4.865362,"median":-1.812562,"eighty":-0.882748,"marketCap":7433517},{"date":"2024-08-23","current":-0.634248,"twenty":-4.861812,"median":-1.808531,"eighty":-0.877583,"marketCap":7720090},{"date":"2024-08-30","current":-0.539004,"twenty":-4.845032,"median":-1.7988,"eighty":-0.861912,"marketCap":6560774},{"date":"2024-09-06","current":-0.506899,"twenty":-4.840837,"median":-1.788971,"eighty":-0.852113,"marketCap":6169993},{"date":"2024-09-13","current":-0.470871,"twenty":-4.840514,"median":-1.779252,"eighty":-0.831376,"marketCap":5731450},{"date":"2024-09-20","current":-0.48835,"twenty":-4.829004,"median":-1.769115,"eighty":-0.81762,"marketCap":5944209},{"date":"2024-09-27","current":-0.4459,"twenty":-4.819862,"median":-1.760037,"eighty":-0.809409,"marketCap":5427510},{"date":"2024-10-04","current":-0.434788,"twenty":-4.818787,"median":-1.749456,"eighty":-0.802566,"marketCap":5292256},{"date":"2024-10-11","current":-0.379015,"twenty":-4.809752,"median":-1.732746,"eighty":-0.786754,"marketCap":4613383},{"date":"2024-10-18","current":-0.461953,"twenty":-4.802757,"median":-1.727438,"eighty":-0.774201,"marketCap":5622900},{"date":"2024-10-25","current":-1.225578,"twenty":-4.80211,"median":-1.713877,"eighty":-0.774201,"marketCap":8082838},{"date":"2024-10-31","current":-1.1105,"twenty":-4.794365,"median":-1.709745,"eighty":-0.778597,"marketCap":7323886},{"date":"2024-11-08","current":-1.193931,"twenty":-4.775002,"median":-1.695984,"eighty":-0.785429,"marketCap":7874127},{"date":"2024-11-15","current":-0.960899,"twenty":-4.763384,"median":-1.691024,"eighty":-0.78654,"marketCap":6337249},{"date":"2024-11-22","current":-0.968091,"twenty":-4.763384,"median":-1.686547,"eighty":-0.786754,"marketCap":6384683},{"date":"2024-11-29","current":-0.972407,"twenty":-4.761557,"median":-1.679045,"eighty":-0.787344,"marketCap":6413144},{"date":"2024-12-06","current":-0.647312,"twenty":-4.749947,"median":-1.668465,"eighty":-0.786468,"marketCap":4269105},{"date":"2024-12-13","current":-0.482122,"twenty":-4.724132,"median":-1.659221,"eighty":-0.775508,"marketCap":3179655},{"date":"2024-12-20","current":-0.585434,"twenty":-4.68541,"median":-1.651388,"eighty":-0.770766,"marketCap":3861009},{"date":"2024-12-27","current":-0.457524,"twenty":-4.6682,"median":-1.645897,"eighty":-0.761733,"marketCap":3017427},{"date":"2025-01-03","current":-0.536238,"twenty":-4.6682,"median":-1.636024,"eighty":-0.749567,"marketCap":3536555},{"date":"2025-01-10","current":-0.592813,"twenty":-4.6682,"median":-1.631718,"eighty":-0.747047,"marketCap":3909677},{"date":"2025-01-17","current":-0.5018,"twenty":-4.66722,"median":-1.630323,"eighty":-0.741703,"marketCap":3309436},{"date":"2025-01-24","current":-0.457524,"twenty":-4.666567,"median":-1.614006,"eighty":-0.729372,"marketCap":3017427},{"date":"2025-01-31","current":-0.487042,"twenty":-4.658822,"median":-1.612138,"eighty":-0.712569,"marketCap":3212100},{"date":"2025-02-07","current":-0.474742,"twenty":-4.646997,"median":-1.602997,"eighty":-0.695074,"marketCap":3130986},{"date":"2025-02-14","current":-0.565755,"twenty":-4.638082,"median":-1.584927,"eighty":-0.68556,"marketCap":3731227},{"date":"2025-02-21","current":-0.50426,"twenty":-4.61409,"median":-1.57882,"eighty":-0.67429,"marketCap":3325659},{"date":"2025-02-28","current":-0.447685,"twenty":-4.567927,"median":-1.572722,"eighty":-0.67154,"marketCap":2952536},{"date":"2025-03-07","current":-0.403408,"twenty":-4.556335,"median":-1.561266,"eighty":-0.665519,"marketCap":2660527},{"date":"2025-03-14","current":-0.37635,"twenty":-4.533632,"median":-1.557004,"eighty":-0.654678,"marketCap":2482077},{"date":"2025-03-21","current":-0.368971,"twenty":-4.508548,"median":-1.535861,"eighty":-0.647326,"marketCap":2433409},{"date":"2025-03-28","current":-0.37635,"twenty":-4.483193,"median":-1.529496,"eighty":-0.637956,"marketCap":2482077},{"date":"2025-04-04","current":-0.366511,"twenty":-4.411341,"median":-1.523784,"eighty":-0.634433,"marketCap":2417186},{"date":"2025-04-11","current":-0.332098,"twenty":-4.329163,"median":-1.516749,"eighty":-0.632639,"marketCap":2190230},{"date":"2025-04-17","current":-0.351752,"twenty":-4.324001,"median":-1.513745,"eighty":-0.629089,"marketCap":2319850},{"date":"2025-04-25","current":-0.368971,"twenty":-4.237951,"median":-1.504693,"eighty":-0.623306,"marketCap":2433409},{"date":"2025-05-02","current":-0.368971,"twenty":-4.216438,"median":-1.494086,"eighty":-0.617126,"marketCap":2433409},{"date":"2025-05-09","current":-0.405868,"twenty":-4.188472,"median":-1.49296,"eighty":-0.609042,"marketCap":2676750},{"date":"2025-05-16","current":-0.396029,"twenty":-4.164808,"median":-1.488974,"eighty":-0.603136,"marketCap":2611859},{"date":"2025-05-23","current":-1.59704,"twenty":-4.141145,"median":-1.485672,"eighty":-0.608505,"marketCap":3163432},{"date":"2025-05-30","current":-3.732469,"twenty":-4.141145,"median":-1.489861,"eighty":-0.608603,"marketCap":7393311},{"date":"2025-06-06","current":-3.31775,"twenty":-3.943231,"median":-1.493014,"eighty":-0.608837,"marketCap":6571832},{"date":"2025-06-13","current":-3.812222,"twenty":-4.082176,"median":-1.494206,"eighty":-0.609012,"marketCap":7551288},{"date":"2025-06-20","current":-3.76437,"twenty":-3.963225,"median":-1.504693,"eighty":-0.61004,"marketCap":7456502},{"date":"2025-06-27","current":-4.051483,"twenty":-3.956844,"median":-1.513745,"eighty":-0.611777,"marketCap":8025218},{"date":"2025-07-03","current":-3.891976,"twenty":-4.111661,"median":-1.516749,"eighty":-0.614047,"marketCap":7709265},{"date":"2025-07-11","current":-3.572962,"twenty":-4.061054,"median":-1.523784,"eighty":-0.616678,"marketCap":7077358},{"date":"2025-07-18","current":-3.588912,"twenty":-3.988391,"median":-1.529496,"eighty":-0.617993,"marketCap":7108953},{"date":"2025-07-25","current":-3.445356,"twenty":-3.893042,"median":-1.535861,"eighty":-0.619853,"marketCap":6824595},{"date":"2025-08-01","current":-2.934933,"twenty":-3.891976,"median":-1.557004,"eighty":-0.620757,"marketCap":5813544},{"date":"2025-08-08","current":-3.222046,"twenty":-3.887523,"median":-1.561266,"eighty":-0.621834,"marketCap":6382260},{"date":"2025-08-15","current":-4.163138,"twenty":-3.887523,"median":-1.572722,"eighty":-0.623973,"marketCap":8246386},{"date":"2025-08-22","current":-4.434301,"twenty":-4.032342,"median":-1.57882,"eighty":-0.62587,"marketCap":8783507},{"date":"2025-08-29","current":-3.509159,"twenty":-4.032342,"median":-1.587084,"eighty":-0.627758,"marketCap":6950977},{"date":"2025-09-05","current":-3.174193,"twenty":-3.98449,"median":-1.59704,"eighty":-0.628679,"marketCap":6287474},{"date":"2025-09-12","current":-3.429405,"twenty":-3.905092,"median":-1.608207,"eighty":-0.629705,"marketCap":6793000},{"date":"2025-09-19","current":-3.285849,"twenty":-3.893397,"median":-1.612236,"eighty":-0.632229,"marketCap":6508642},{"date":"2025-09-26","current":-3.285849,"twenty":-3.891976,"median":-1.629992,"eighty":-0.632491,"marketCap":6508642},{"date":"2025-10-03","current":-3.381553,"twenty":-3.891976,"median":-1.631699,"eighty":-0.632639,"marketCap":6698214},{"date":"2025-10-10","current":-3.585231,"twenty":-3.88975,"median":-1.636024,"eighty":-0.632827,"marketCap":7764344},{"date":"2025-10-17","current":-3.125094,"twenty":-3.87988,"median":-1.649785,"eighty":-0.632982,"marketCap":6767851},{"date":"2025-10-24","current":-2.530751,"twenty":-3.872835,"median":-1.653701,"eighty":-0.633675,"marketCap":5480713},{"date":"2025-10-30","current":-1.418754,"twenty":-3.860074,"median":-1.657602,"eighty":-0.634248,"marketCap":3072521}],"updateTime":1773401283047},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NLSP\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2574247271","title":"Kadimastem Ltd Subsidiary of NLS Pharmaceutics Ltd Reports Six Month Loss of 11204 Thousand USD on No Reported Sales or Revenues with Increased Net Loss and No EPS Data Provided","url":"https://stock-news.laohu8.com/highlight/detail?id=2574247271","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574247271?lang=en_us&edition=fundamental","pubTime":"2025-10-10 18:02","pubTimestamp":1760090542,"startTime":"0","endTime":"0","summary":"Kadimastem Ltd Subsidiary of NLS Pharmaceutics Ltd Reports Six Month Loss of 11204 Thousand USD on No Reported Sales or Revenues with Increased Net Loss and No EPS Data Provided. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NLS Pharmaceutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 10, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251010:nNDL3b0gD1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NLSP","BK4007"],"gpt_icon":0},{"id":"2573679864","title":"NLS Pharmaceutics H1 EPS $(1.05) Up From $(1.94) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2573679864","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573679864?lang=en_us&edition=fundamental","pubTime":"2025-10-06 18:49","pubTimestamp":1759747798,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics H1 EPS $(1.05) Up From $(1.94) YoY","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/10/48037509/nls-pharmaceutics-h1-eps-1-05-up-from-1-94-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NLSP"],"gpt_icon":0},{"id":"2571534166","title":"NLS Pharmaceutics Shareholders Approve Merger with Kadimastem, Paving Way for Launch of NewCelX on Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2571534166","media":"Reuters","labels":["executive","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571534166?lang=en_us&edition=fundamental","pubTime":"2025-09-30 19:15","pubTimestamp":1759230930,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics AG announced that its shareholders have approved the proposed merger with Kadimastem Ltd., clearing the final corporate milestone ahead of closing. The combined company will be renamed NewCelX Ltd. and is set to be listed on Nasdaq under the ticker symbol \"NCEL.\" Upon completion, Kadimastem shareholders will own approximately 84.4% of the merged entity, while NLS shareholders will hold 15.6%. The merger brings together Kadimastem's advanced cell therapy programs, including a Phase 2a ALS study of AstroRx and the IsletRx diabetes candidate, with NLS's expertise in CNS small-molecule therapies. The leadership team will be headed by Ronen Twito as Executive Chairman and CEO of NewCelX.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or le","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nNDL2z7n77:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NLSP"],"gpt_icon":0},{"id":"2571492073","title":"BRIEF-NLS Pharmaceutics Shareholders Approve Merger with Kadimastem and Related Proposals at Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2571492073","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571492073?lang=en_us&edition=fundamental","pubTime":"2025-09-30 19:03","pubTimestamp":1759230214,"startTime":"0","endTime":"0","summary":"BRIEF-NLS Pharmaceutics Shareholders Approve Merger with Kadimastem and Related Proposals at Extraordinary General MeetingSept 30 (Reuters) - Kadimastem Ltd KDST.TA:NLS PHARMACEUTICS SHAREHOLDERS APPR","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nTUA3GYGFR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NLSP","BK4007"],"gpt_icon":0},{"id":"2570704120","title":"NLS Pharmaceutics files to sell 5M common shares for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2570704120","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570704120?lang=en_us&edition=fundamental","pubTime":"2025-09-26 04:55","pubTimestamp":1758833729,"startTime":"0","endTime":"0","summary":"16:50 EDT NLS Pharmaceutics (NLSP) files to sell 5M common shares for holders Published first on TheFly – the ultimate source for real-time, market...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nls-pharmaceutics-files-to-sell-5m-common-shares-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nls-pharmaceutics-files-to-sell-5m-common-shares-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","NLSP"],"gpt_icon":0},{"id":"2569719704","title":"NLS Pharmaceutics AG Appoints CBIZ as New Auditor Amid Internal Control Weaknesses","url":"https://stock-news.laohu8.com/highlight/detail?id=2569719704","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569719704?lang=en_us&edition=fundamental","pubTime":"2025-09-23 23:13","pubTimestamp":1758640438,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics AG has announced a change in its independent registered public accounting firm following the acquisition of Marcum LLP's attestation business by CBIZ CPAs P.C. As of September 17, 2025, Marcum LLP resigned as the company's auditor, and CBIZ was engaged to take over the role for the fiscal year ending December 31, 2025. The transition was approved by the Audit Committee of NLS Pharmaceutics' Board of Directors. Notably, Marcum's report on the company's financial statements for the fiscal year ended December 31, 2024, did not contain any adverse opinions or disclaimers but did highlight substantial doubt about the company's ability to continue as a going concern. Additionally, the company disclosed material weaknesses in its internal control over financial reporting, specifically related to a lack of trained accounting professionals and insufficient segregation of duties.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250923:nNDL8mFzs8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4123","LU2065732104.USD","NLSP","CBZ","BK4007"],"gpt_icon":0},{"id":"2568918832","title":"NLS Pharmaceutics Engages New Accounting Firm After Marcum’s Resignation","url":"https://stock-news.laohu8.com/highlight/detail?id=2568918832","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568918832?lang=en_us&edition=fundamental","pubTime":"2025-09-20 04:28","pubTimestamp":1758313731,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics ( ($NLSP) ) just unveiled an update. On September 17, 2025, NLS Pharmaceutics Ltd. announced a change in its independent register...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nls-pharmaceutics-engages-new-accounting-firm-after-marcums-resignation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nls-pharmaceutics-engages-new-accounting-firm-after-marcums-resignation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","NLSP"],"gpt_icon":0},{"id":"2566708806","title":"BRIEF-Kadimastem, NLS Pharmaceutics Announce Effectiveness Of SEC Registration Statement For Proposed Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2566708806","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566708806?lang=en_us&edition=fundamental","pubTime":"2025-09-10 18:32","pubTimestamp":1757500362,"startTime":"0","endTime":"0","summary":"BRIEF-Kadimastem, NLS Pharmaceutics Announce Effectiveness Of SEC Registration Statement For Proposed MergerSept 10 (Reuters) - NLS Pharmaceutics NLSP.O:KADIMASTEM AND NLS PHARMACEUTICS ANNOUNCE EFFEC","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250910:nTUA1X4D3X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NLSP","BK4007"],"gpt_icon":0},{"id":"2566677632","title":"NLS Pharmaceutics and Kadimastem Secure SEC Approval for Merger, Set to Form NewCelX Ltd","url":"https://stock-news.laohu8.com/highlight/detail?id=2566677632","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566677632?lang=en_us&edition=fundamental","pubTime":"2025-09-10 18:16","pubTimestamp":1757499376,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics AG and Kadimastem Ltd. have announced that the U.S. Securities and Exchange Commission has declared effective their registration statement on Form F-4 related to their proposed merger. This marks the final regulatory step needed for closing the merger. Upon completion, the combined company will be known as NewCelX Ltd. and will continue to be publicly traded on Nasdaq under the ticker \"NCEL.\" The merger will unite Kadimastem's cell therapy platforms with NLS's expertise in small-molecule therapies, creating a diversified pipeline targeting CNS disorders and metabolic diseases.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NLS Pharmaceutics Ltd. published the original content used to generate this news brief via EDGAR","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250910:nNDLtdHtZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NLSP","BK4007"],"gpt_icon":0},{"id":"2566672734","title":"Press Release: Kadimastem and NLS Pharmaceutics Announce Effectiveness of SEC Registration Statement in Connection with Proposed Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2566672734","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566672734?lang=en_us&edition=fundamental","pubTime":"2025-09-10 18:00","pubTimestamp":1757498400,"startTime":"0","endTime":"0","summary":"ZURICH and NESS ZIONA, Israel, Sept. 10, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd.  , a Swiss clinical-stage biopharmaceutical company focused on central nervous system  disorders, and Kadimastem Ltd.  , an advanced clinical-stage cell therapy company progressing treatments for neurodegenerative diseases and diabetes, today announced that the U.S. Securities and Exchange Commission  has declared effective the registration statement on Form F-4 related to the companies' previously announced merger. The Form F-4 became effective on September 9, 2025, at 4:00 p.m. Eastern Time.This marks the final U.S. federal securities regulatory hurdle required for closing the merger. Upon completion, the combined company -- to be known as NewCelX Ltd. -- will remain a publicly traded biotechnology company listed on Nasdaq under the ticker \"NCEL\", uniting Kadimastem's proprietary cell therapy platforms with NLS's expertise in small-molecule therapies.Ronen Twito, Executive Chairman and CEO of Kadimas","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4232","BK4007","NQmain","R","NLSP"],"gpt_icon":0},{"id":"2564583372","title":"NLS Pharmaceutics and Kadimastem Secure Hong Kong Patent for IsletRx Cell-Selection Technology in Diabetes Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2564583372","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564583372?lang=en_us&edition=fundamental","pubTime":"2025-09-04 20:40","pubTimestamp":1756989611,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics AG and Kadimastem Ltd. have announced the granting of a patent by the Hong Kong Intellectual Property Department for Kadimastem's proprietary cell selection and enrichment technology. This technology is used in the development of IsletRx, a stem cell-derived therapy candidate aimed at treating insulin-dependent diabetes. The newly granted patent in Hong Kong complements previously secured patents in Europe, the United States, and India, further strengthening the global protection for IsletRx. This milestone supports the long-term strategy for advancing Kadimastem's diabetes program and underscores the potential of IsletRx as a curative cell therapy for diabetes patients worldwide.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or lega","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250904:nNDL5BlHc9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NLSP"],"gpt_icon":0},{"id":"2564089384","title":"Swiss stocks - Factors to watch on September 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2564089384","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564089384?lang=en_us&edition=fundamental","pubTime":"2025-09-01 12:57","pubTimestamp":1756702671,"startTime":"0","endTime":"0","summary":"Swiss stocks - Factors to watch on September 1 ZURICH/GDANSK, Sept 1 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Monday:EMS CHEMIE HOLDING EMSN.S Alexander Hergert, c","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250901:nL8N3UL0ZZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NLSP","BK4007"],"gpt_icon":0},{"id":"2563745110","title":"BRIEF-NLS Pharmaceutics AG Agreed To Extend Merger Agreement Termination Date With Kadimastem From Aug 31 To Oct 31","url":"https://stock-news.laohu8.com/highlight/detail?id=2563745110","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563745110?lang=en_us&edition=fundamental","pubTime":"2025-08-30 04:26","pubTimestamp":1756499207,"startTime":"0","endTime":"0","summary":"BRIEF-NLS Pharmaceutics AG Agreed To Extend Merger Agreement Termination Date With Kadimastem From Aug 31 To Oct 31Aug 29  - NLS Pharmaceutics AG NLSP.O:NLS PHARMACEUTICS AG: AGREED TO EXTEND MERGER AGREEMENT TERMINATION DATE WITH KADIMASTEM FROM AUG 31 TO OCT 31- SEC FILINGFurther company coverage: NLSP.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250829:nFWN3UL11Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NLSP","BK4007"],"gpt_icon":0},{"id":"2563597074","title":"NLS Pharmaceutics Ag: Agreed to Extend Merger Agreement Termination Date With Kadimastem From Aug 31 to Oct 31- SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2563597074","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563597074?lang=en_us&edition=fundamental","pubTime":"2025-08-30 04:25","pubTimestamp":1756499123,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250829:nFWN3UL11Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NLSP"],"gpt_icon":0},{"id":"2563071495","title":"NLS Pharmaceutics AG Announces Seventh Amendment to Merger Agreement with Kadimastem Ltd","url":"https://stock-news.laohu8.com/highlight/detail?id=2563071495","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563071495?lang=en_us&edition=fundamental","pubTime":"2025-08-30 04:01","pubTimestamp":1756497698,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics AG has announced a significant update to its merger and reorganization plans with Kadimastem Ltd. The Seventh Amendment to the Agreement of Merger and Plan of Reorganization was executed on August 29, 2025. This amendment involves NLS Pharmaceutics Ltd., NLS Pharmaceuticals  Ltd., and Kadimastem Ltd., a publicly traded Israeli company. The amendment was signed by key representatives, including Alexander C. Zwyer, CEO of NLS Pharmaceutics Ltd., and Ronen Twito, CEO of Kadimastem Ltd. This update marks a continued collaboration between the companies, as they work towards completing the merger process.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NLS Pharmaceutics Ltd. published the original content used to generate th","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250829:nNDLbgjzDS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NLSP","BK4007"],"gpt_icon":0},{"id":"2557737480","title":"NLS Pharmaceutics AG Announces New Shareholder Agreement with Alpha Capital Anstalt to Exchange Warrants for Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2557737480","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557737480?lang=en_us&edition=fundamental","pubTime":"2025-08-06 20:01","pubTimestamp":1754481693,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics AG has announced a new shareholder agreement with Alpha Capital Anstalt. The agreement, dated August 5, 2025, involves the exchange of a warrant held by Alpha Capital Anstalt for 207,913 shares of NLS Pharmaceutics' common shares. In return, the company will issue 100,000 common shares to the holder. This exchange is executed under an exemption from registration pursuant to the Securities Act of 1933. The agreement includes a waiver by the holder of any liquidated damages related to past securities registration obligations. The transaction is set to be completed within one trading day, and the new shares will carry the same rights as the previously held warrant shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NL","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250806:nNDL8MQC4N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NLSP"],"gpt_icon":0},{"id":"2552149746","title":"NLS Pharmaceutics AG Announces Sixth Amendment to Merger Agreement with Kadimastem Ltd","url":"https://stock-news.laohu8.com/highlight/detail?id=2552149746","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552149746?lang=en_us&edition=fundamental","pubTime":"2025-07-19 04:06","pubTimestamp":1752869165,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics AG announced an update regarding its merger and reorganization agreement with Kadimastem Ltd. The Sixth Amendment to the agreement, dated July 18, 2025, involves NLS Pharmaceutics Ltd., Kadimastem Ltd., and NLS Pharmaceuticals  Ltd. This amendment revises Section 2.1.3 of the original agreement, stipulating that NLS Pharmaceutics Ltd. will deliver a certified statement outlining its estimates of closing indebtedness, cash, and adjusted cash amount, along with the resulting merger consideration to be issued. The update highlights the ongoing collaboration and steps toward finalizing the merger process.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NLS Pharmaceutics Ltd. published the original content used to generate ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250718:nNDL8bqjTp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NLSP","BK4007"],"gpt_icon":0},{"id":"2552282481","title":"NLS Pharmaceutics AG and Kadimastem Secure Milestone-Based Funding from BIRD Foundation Following FDA Pre-IND Success for iTOL-102, a Potential Cure for Type 1 Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2552282481","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552282481?lang=en_us&edition=fundamental","pubTime":"2025-07-17 21:00","pubTimestamp":1752757243,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics AG and Kadimastem Secure Milestone-Based Funding from BIRD Foundation Following FDA Pre-IND Success for iTOL-102, a Potential Cure for Type 1 Diabetes. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NLS Pharmaceutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 17, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nNDLc41VNl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NLSP"],"gpt_icon":0},{"id":"2548887309","title":"NLS Pharmaceutics AG Held Extraordinary Shareholders' Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2548887309","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548887309?lang=en_us&edition=fundamental","pubTime":"2025-07-02 04:31","pubTimestamp":1751401895,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics AG held an extraordinary shareholders' meeting on June 30, 2025. All agenda items presented at the meeting were approved by the shareholders.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NLS Pharmaceutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 01, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nNDL3K5ctP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NLSP"],"gpt_icon":0},{"id":"2548882629","title":"NLS Pharmaceutics AG Announces Fifth Amendment to Merger Agreement with Kadimastem Ltd","url":"https://stock-news.laohu8.com/highlight/detail?id=2548882629","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548882629?lang=en_us&edition=fundamental","pubTime":"2025-07-02 04:01","pubTimestamp":1751400102,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics AG has announced a significant update to its merger and reorganization plans with Kadimastem Ltd. The two companies have entered into a Fifth Amendment to their Agreement of Merger and Plan of Reorganization. This amendment, effective as of July 1, 2025, involves NLS Pharmaceutics Ltd., its Israeli subsidiary NLS Pharmaceuticals  Ltd., and Kadimastem Ltd., an Israeli publicly traded company. The amendment outlines further commitments to carry out the merger provisions and signifies continued progress towards the planned reorganization. The companies involved have expressed their commitment to executing the necessary documents and actions to fulfill the amendment's provisions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal adv","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nNDL86DgX1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NLSP","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":47,"code":"91000000","status":"200"}]}}